Can aplastic anemia be cured completely?

Written by Li Fang Fang

Hematology

Updated on November 10, 2024

00:00

00:00

Aplastic anemia clinically is categorized into acute aplastic anemia and chronic aplastic anemia. Acute aplastic anemia appears suddenly and is severe, with a short survival period. Chronic aplastic anemia develops slowly, has a longer history, and is relatively milder in condition. Whether it is acute aplastic anemia or chronic aplastic anemia, curative treatment can only be achieved through allogeneic hematopoietic stem cell transplantation. Although allogeneic hematopoietic stem cell transplantation offers a potential cure for aplastic anemia, there is also a certain rate of failure. Additionally, post-transplant, there is a presence of immune rejection.

Other Voices

home-news-image

Written by Li Fang Fang

Hematology

59sec

home-news-image

Is aplastic anemia contagious?

Aplastic anemia is not contagious and has a minor hereditary factor, meaning that if a family member has aplastic anemia, it is generally not inherited by the next generation. The cause of aplastic anemia is still unclear, but possible reasons include: 1. Damage to hematopoietic stem cells. After the hematopoietic stem cells are damaged, it leads to limited stem cell proliferation and reduced hematopoiesis. 2. Damage to the hematopoietic microenvironment. Damage to the hematopoietic microenvironment can lead to changes that disrupt the regeneration of hematopoietic stem cells. 3. Immune factors. Immune factors can cause immune damage, directly damaging hematopoietic stem cells, thereby causing bone marrow regeneration disorders.

home-news-image

Written by Li Fang Fang

Hematology

39sec

home-news-image

Aplastic anemia is caused by how?

Aplastic anemia currently still has an uncertain etiology. However, clinical observations have suggested that chemotherapy drugs, viral infections, and radiation exposure might be related to the occurrence and development of aplastic anemia. Regardless of the cause, these factors all involve abnormalities in immune function. Abnormal immune function leads to the occurrence and development of aplastic anemia. Therefore, immunosuppressive therapy is often effective for patients with aplastic anemia in clinical settings. (Medication use should be conducted under the guidance of a professional doctor.)

home-news-image

Written by Zhang Xiao Le

Hematology

42sec

home-news-image

Is it good to transfuse platelets for aplastic anemia with low platelets?

Aplastic anemia is a type of bone marrow failure syndrome, with patients often experiencing a decrease in all blood cells in the peripheral blood. As a result, patients typically face a higher risk of infections and bleeding. Treatment for aplastic anemia is a long-term process, and hematopoiesis often cannot be restored quickly. Therefore, especially in severe cases of aplastic anemia, patients' blood cells remain at relatively low levels for an extended period, placing them at severe risk of infections and bleeding. If platelets fall below 20*10^9/L, it is necessary to administer platelet transfusions to prevent severe bleeding.

home-news-image

Written by Li Fang Fang

Hematology

52sec

home-news-image

How long can one live with aplastic anemia?

The lifespan of patients with aplastic anemia depends on the type and the effectiveness of the treatment. Aplastic anemia is classified into acute aplastic anemia and chronic aplastic anemia. In cases of acute aplastic anemia, cure is possible through intensified immunotherapy or hematopoietic stem cell transplantation; however, without aggressive treatment, the survival period is relatively short, generally not exceeding one year. Chronic aplastic anemia, on the other hand, has a longer medical history, and patients can often live for ten to twenty years or more. However, throughout this period, ongoing transfusions of red blood cells and platelets are required to support treatment.

home-news-image

Written by Li Fang Fang

Hematology

40sec

home-news-image

Aplastic anemia is caused by how?

The etiology of aplastic anemia is unclear. A more classical theory is the seed, soil, and bug theory. The seed theory suggests that patients with this condition have reduced hematopoietic stem cells in the bone marrow, leading to bone marrow failure. The soil theory refers to abnormal microenvironments in the bone marrow of patients, which leads to an abnormal growth environment for stem cells and consequently hematopoietic disturbances. The bug theory, which is commonly referred to in clinical settings as immune dysfunction, plays a major role in the etiology of this condition.